By the Top Tier Newswire AI Desk · August 6, 2026 at 12:05 AM ET · reviewed against 1 wire stories
INSULET CORP (PODD) is drawing unusual attention today. Our newswire has captured 1 story on PODD across 1 source in the last 36 hours, with AI sentiment reading bearish (avg 34/100).
Public view, delayed 4h. Every headline, price and sentiment read below — and this write-up itself — reaches Pro subscribers live. Public readers see it once it clears the delay.
PODD stock fell 20.12% to $133.26 in a session marked by multiple analyst downgrades and a revised outlook from the company. The decline followed a series of analyst actions targeting Insulet’s growth trajectory, particularly in the competitive insulin pump market and concerns over type 2 diabetes retention. Despite beating second-quarter 2026 earnings estimates, the company cut its full-year revenue guidance, contributing to the sharp sell-off.
What Happened
Truist, Stifel, and Oppenheimer all downgraded Insulet stock within the last 36 hours, citing challenges in market retention and competition. Truist and Oppenheimer highlighted concerns over churn and growth in the type 2 diabetes segment, while Stifel reduced its price target due to pump market dynamics. Insulet’s own earnings call revealed a revised 2026 revenue growth forecast of 20%-22% amid adjustments to U.S. assumptions. The company also cut its full-year sales guidance from $3.277B to $3.331B to $3.250B to $3.304B. These developments contributed to a sharp drop in investor sentiment.
What The Data Shows
The stock has fallen 19.2% over the last eight sessions, from $165.00 to $133.26, and currently trades within its 52-week range of $138.79 to $354.88. Insulet’s market cap is $11.8B, with a P/E of 38.9 and a beta of 1.09. Recent insider transactions show mixed activity, with three directors buying shares on June 3 and one selling. Congressional trades include three buys and four sells by Donald J. Trump in the last 90 days. The stock’s intraday volume was unusually high, though no unusual options activity was reported.
What To Watch
The company’s guidance cut and analyst downgrades suggest continued scrutiny ahead. Investors should monitor the 2027 outlook for clarity on type 2 diabetes retention and market share dynamics. Coverage breadth remains elevated, with 20 stories from 12 sources in the last 36 hours.
AI-assisted analysis composed exclusively from headlines and data on the Top Tier newswire. Public view is delayed 4 hours from real time. Not financial advice.
PODD · Aug 6 session (5-min) · +4.23% vs prior close · updated 8:44 PM ETAI sentiment, last 36h · averaged over 1 story · 34/100 bearish
The headlines behind the move
Story flow · 1 story on the wire, last 36h · hover or tap a dot for the headline
12h agoPR NewswireBEARISH 34General
Insulet Corporation Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - PODD
LOS ANGELES, Aug. 10, 2026 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Insulet Corporation ("Insulet" or "the Company") (NASDAQ: PODD) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder...
Frequently asked questions
Why is PODD stock moving today?
INSULET CORP (PODD) is drawing unusual attention today. Our newswire has captured 1 story on PODD across 1 source in the last 36 hours, with AI sentiment reading bearish (avg 34/100). The most recent driver: "Insulet Corporation Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - PODD" (PR Newswire).
Is PODD a buy right now?
Top Tier Newswire does not give financial advice. Our AI sentiment across the last 36 hours of PODD coverage reads 34/100 over 1 stories; treat it as a research signal and do your own diligence.
How fast does this page update?
The data sections refresh continuously as the newswire lands coverage; the written analysis is published once per trading day. Pro subscribers additionally get real-time push alerts, watchlists, and the full live terminal.
Want the next move before the crowd? The live terminal streams every headline in real time with watchlist alerts, AI sentiment, and the full data stack behind this page.Get Pro Access →